Yiting Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yiting Li has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Mara A. McAdams DeMarco
Department of Surgery New York University New York New York USA
24 shared publications - Dorry Lidor Segev
Department of Surgery New York University New York New York USA
18 shared publications - Babak J. Orandi
Department of Surgery New York University New York New York USA
10 shared publications - Jingyao Hong
Department of Surgery New York University, Grossman School of Medicine and Langone Health New York New York USA
9 shared publications Byoungjun Kim
Department of Surgery New York University Grossman School of Medicine New York New York USA
7 shared publications- Sunjae Bae
Department of Surgery, NYU Langone Health, New York, New York
7 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 2114-2127
Changes in Depressive Symptoms Pre- and Post-Kidney Transplantation
Key Points: Depressive symptoms increased modestly during the first 4 years after kidney transplant but remained below the threshold for clinical depression. Post-kidney transplant Center for Epidemiologic Studies Depression scores improved in recipients with high pre-kidney transplant depressive symptoms. Clinicians should counsel patients on the potential mental health implications of kidney transplant and individualize care decisions accordingly. Background: Depressive symptoms are common in patients with ESKD and may persist after stopping dialysis because of challenges post-kidney transplant (KT) despite clinical benefits. We sought to assess changes in depressive symptoms pre- and post-KT. Methods: We leveraged a multicenter prospective cohort of 4661 adult (aged ≥18) potential KT candidates and 1215 recipients (2008–2025). Participants reported depressive symptoms via the Center for Epidemiologic Studies Depression (CES-D) scale (range 0–60, high depressive symptoms ≥16) at evaluation, KT, and post-KT. We used linear mixed-effect models to estimate post-KT trajectories of CES-D scores overall and by characteristics at KT admission. Results: Nineteen percentage of potential candidates at evaluation and 15% of recipients at admission had depressive symptoms; 46% and 38%, respectively, were non-Hispanic Black. Over the first 4 years post-KT, depressive symptoms slightly worsened (slope=0.4 points/yr, 95% confidence interval [CI], 0.3 to 0.6) but remained below the threshold for clinical depression. Post-KT, CES-D score change differed by pre-KT high depressive symptoms score (difference=−1.2 points/yr, 95% CI, −1.8 to −0.6). Specifically, post-KT depressive symptoms were 0.7 points/yr lower (95% CI, −1.2 to −0.1) among recipients with pre-KT high depressive symptoms and 0.5 points/yr higher (95% CI, 0.3 to 0.7) among those without. CES-D score change also differed by preemptive KT status (difference=−0.6 points/yr, 95% CI, −1.0 to −0.1, non-preemptive versus preemptive). Conclusions: Depressive symptoms worsened slightly over the first 4 years post-KT but remained below the threshold for clinical depression. Notably, post-KT CES-D scores decreased in recipients with high pre-KT depressive symptoms. Clinicians should discuss the mental health impact of KT with patients and tailor care decisions to individual needs.
- 24 June 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 2114-2127
Open AccessChanges in Depressive Symptoms Pre- and Post-Kidney Transplantation
Key Points: Depressive symptoms increased modestly during the first 4 years after kidney transplant but remained below the threshold for clinical depression. Post-kidney transplant Center for Epidemiologic Studies Depression scores improved in recipients with high pre-kidney transplant depressive symptoms. Clinicians should counsel patients on the potential mental health implications of kidney transplant and individualize care decisions accordingly. Background: Depressive symptoms are common in patients with ESKD and may persist after stopping dialysis because of challenges post-kidney transplant (KT) despite clinical benefits. We sought to assess changes in depressive symptoms pre- and post-KT. Methods: We leveraged a multicenter prospective cohort of 4661 adult (aged ≥18) potential KT candidates and 1215 recipients (2008–2025). Participants reported depressive symptoms via the Center for Epidemiologic Studies Depression (CES-D) scale (range 0–60, high depressive symptoms ≥16) at evaluation, KT, and post-KT. We used linear mixed-effect models to estimate post-KT trajectories of CES-D scores overall and by characteristics at KT admission. Results: Nineteen percentage of potential candidates at evaluation and 15% of recipients at admission had depressive symptoms; 46% and 38%, respectively, were non-Hispanic Black. Over the first 4 years post-KT, depressive symptoms slightly worsened (slope=0.4 points/yr, 95% confidence interval [CI], 0.3 to 0.6) but remained below the threshold for clinical depression. Post-KT, CES-D score change differed by pre-KT high depressive symptoms score (difference=−1.2 points/yr, 95% CI, −1.8 to −0.6). Specifically, post-KT depressive symptoms were 0.7 points/yr lower (95% CI, −1.2 to −0.1) among recipients with pre-KT high depressive symptoms and 0.5 points/yr higher (95% CI, 0.3 to 0.7) among those without. CES-D score change also differed by preemptive KT status (difference=−0.6 points/yr, 95% CI, −1.0 to −0.1, non-preemptive versus preemptive). Conclusions: Depressive symptoms worsened slightly over the first 4 years post-KT but remained below the threshold for clinical depression. Notably, post-KT CES-D scores decreased in recipients with high pre-KT depressive symptoms. Clinicians should discuss the mental health impact of KT with patients and tailor care decisions to individual needs.
- 30 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (5) , e70553
The Association Between Post‐Kidney Transplant Persistent Hyperparathyroidism and Fracture Risk: A Longitudinal Cohort Study
Introduction: Hyperparathyroidism (HPT) commonly persists following kidney transplant (KT) and can result in bone alterations. However, the association between persistent HPT post‐KT and fracture risk is not well‐understood. We sought to quantify the association between persistent HPT at 1‐year post‐KT and fracture risk among KT recipients. Methods: We leveraged a longitudinal prospective cohort of 344 adult KT recipients who underwent KT at a single institution (12/2008–07/2019). PTH levels were retroactively abstracted, and fractures after 1‐year‐post‐KT were ascertained using ICD‐9/ICD‐10 codes. Competing risk models were used to estimate the association between persistent HPT (PTH ≥ 70 pg/mL) at 1‐year post‐KT and the risk of fracture, with death treated as a competing event. Results: Among 344 KT recipients, 227 (66.0%) had persistent HPT at 1‐year post‐KT. After adjusting for confounders, HPT 1‐year after KT was associated with a 3.11‐fold increased risk of fractures (95% CI: 1.08–8.91). There were no differences in this association by age, sex, race, eGFR at 1‐year‐post‐KT, osteoporosis at KT, or dialysis vintage. Conclusion: Recipients with HPT 1‐year after KT had a significantly higher risk of fractures than those without persistent HPT. Future studies should establish standardized practice guidelines for the treatment of persistent HPT to mitigate fracture‐related morbidity and mortality.
- 30 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (5) , e70553
The Association Between Post‐Kidney Transplant Persistent Hyperparathyroidism and Fracture Risk: A Longitudinal Cohort Study
Introduction: Hyperparathyroidism (HPT) commonly persists following kidney transplant (KT) and can result in bone alterations. However, the association between persistent HPT post‐KT and fracture risk is not well‐understood. We sought to quantify the association between persistent HPT at 1‐year post‐KT and fracture risk among KT recipients. Methods: We leveraged a longitudinal prospective cohort of 344 adult KT recipients who underwent KT at a single institution (12/2008–07/2019). PTH levels were retroactively abstracted, and fractures after 1‐year‐post‐KT were ascertained using ICD‐9/ICD‐10 codes. Competing risk models were used to estimate the association between persistent HPT (PTH ≥ 70 pg/mL) at 1‐year post‐KT and the risk of fracture, with death treated as a competing event. Results: Among 344 KT recipients, 227 (66.0%) had persistent HPT at 1‐year post‐KT. After adjusting for confounders, HPT 1‐year after KT was associated with a 3.11‐fold increased risk of fractures (95% CI: 1.08–8.91). There were no differences in this association by age, sex, race, eGFR at 1‐year‐post‐KT, osteoporosis at KT, or dialysis vintage. Conclusion: Recipients with HPT 1‐year after KT had a significantly higher risk of fractures than those without persistent HPT. Future studies should establish standardized practice guidelines for the treatment of persistent HPT to mitigate fracture‐related morbidity and mortality.
- 7 January 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (9) , 2697-2703
Neighborhood Ambient Air Pollution and Post‐Transplant Outcomes in Older Kidney Transplant Recipients
Introduction: Elevated concentrations of air pollutants in residential neighborhoods are associated with poorer survival, cognitive, and cardiovascular health among older adults. Older kidney transplant (KT) recipients may be more vulnerable due to chronic immunosuppression and age‐related co‐morbidities. Therefore, we quantified the associations between pollutant concentrations and post‐KT outcomes among older recipients. Methods: We identified older (age ≥ 55) Black and White KT recipients from the national registry (2003–2019) linked to Medicare claims. Annual pollutant concentrations (particulate matter ≤ 2.5 μm [PM 2.5 ], particulate matter ≤ 10 μm, [PM 10 ], nitrogen dioxide [NO 2 ], and sulfur dioxide [SO 2 ]) were obtained from the Center for Air, Climate and Energy Solutions, and matched by ZIP code and year of KT. We used shared frailty models (cluster = state) to estimate the adjusted hazard ratios (aHR) of mortality and death‐censored graft failure (DCGF) and competing risk models with cluster‐robust standard errors to estimate the adjusted subhazard ratios (aSHR) of dementia and stroke by pollutant concentrations. Results: Among 42,199 older KT recipients, 38% were Black, 36% were female, and 82% received deceased donor KT. After adjustment, each standardized increase in pollutant concentrations was associated with significantly higher mortality risk: PM 2.5 (aHR = 1.08, 95% confidence interval [CI]: 1.07–1.10); PM 10 (aHR = 1.05, 95% CI: 1.03–1.07); NO 2 (aHR = 1.04, 95% CI: 1.02–1.06); SO 2 (aHR = 1.09, 95% CI: 1.08–1.11). Similarly, increasing pollutant concentrations were associated with a higher risk of DCGF. Additionally, there were no significant associations between increasing pollutant concentrations and incident dementia/stroke, except: increasing PM 2.5 and NO 2 concentrations were associated with a 3% (aSHR = 1.03, 95% CI: 1.00–1.07) and 4% higher risk of stroke (aSHR = 1.04, 95% CI: 1.02–1.07), respectively. Conclusion: Residence in neighborhoods with high concentrations of ambient air pollutants can worsen patient and graft survival, as well as increase the risk of stroke among older KT recipients. Early screening and interventions targeting older recipients living in such neighborhoods may be crucial for preserving cognitive and cerebrovascular health, as well as improving longitudinal quality of life.
- 7 January 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (9) , 2697-2703
Neighborhood Ambient Air Pollution and Post‐Transplant Outcomes in Older Kidney Transplant Recipients
Introduction: Elevated concentrations of air pollutants in residential neighborhoods are associated with poorer survival, cognitive, and cardiovascular health among older adults. Older kidney transplant (KT) recipients may be more vulnerable due to chronic immunosuppression and age‐related co‐morbidities. Therefore, we quantified the associations between pollutant concentrations and post‐KT outcomes among older recipients. Methods: We identified older (age ≥ 55) Black and White KT recipients from the national registry (2003–2019) linked to Medicare claims. Annual pollutant concentrations (particulate matter ≤ 2.5 μm [PM 2.5 ], particulate matter ≤ 10 μm, [PM 10 ], nitrogen dioxide [NO 2 ], and sulfur dioxide [SO 2 ]) were obtained from the Center for Air, Climate and Energy Solutions, and matched by ZIP code and year of KT. We used shared frailty models (cluster = state) to estimate the adjusted hazard ratios (aHR) of mortality and death‐censored graft failure (DCGF) and competing risk models with cluster‐robust standard errors to estimate the adjusted subhazard ratios (aSHR) of dementia and stroke by pollutant concentrations. Results: Among 42,199 older KT recipients, 38% were Black, 36% were female, and 82% received deceased donor KT. After adjustment, each standardized increase in pollutant concentrations was associated with significantly higher mortality risk: PM 2.5 (aHR = 1.08, 95% confidence interval [CI]: 1.07–1.10); PM 10 (aHR = 1.05, 95% CI: 1.03–1.07); NO 2 (aHR = 1.04, 95% CI: 1.02–1.06); SO 2 (aHR = 1.09, 95% CI: 1.08–1.11). Similarly, increasing pollutant concentrations were associated with a higher risk of DCGF. Additionally, there were no significant associations between increasing pollutant concentrations and incident dementia/stroke, except: increasing PM 2.5 and NO 2 concentrations were associated with a 3% (aSHR = 1.03, 95% CI: 1.00–1.07) and 4% higher risk of stroke (aSHR = 1.04, 95% CI: 1.02–1.07), respectively. Conclusion: Residence in neighborhoods with high concentrations of ambient air pollutants can worsen patient and graft survival, as well as increase the risk of stroke among older KT recipients. Early screening and interventions targeting older recipients living in such neighborhoods may be crucial for preserving cognitive and cerebrovascular health, as well as improving longitudinal quality of life.
- 20 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70388
Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality
Background: Frail kidney transplant (KT) candidates, characterized by low physical activity/function, have decreased chances of listing and increased risk of waitlist mortality. Impairments in these physical domains contribute to perceived physical burden and may exacerbate one another. Further, understanding the association of each domain individually with adverse outcomes may improve pre‐KT risk stratification. Methods: We leveraged 2708 KT candidates (age ≥ 18) from a two‐center prospective cohort study (2014–2024). We assessed physical activity (Minnesota Leisure Time Physical Activity Questionnaire), physical function (gait speed), and physical burden (10 questions from the Kidney Disease Quality of Life Short Form) at evaluation. We quantified the association of these three physical domains with listing (Cox proportional hazards) and waitlist mortality (competing risks, Harrell's C ‐statistic). Results: Among 2708 candidates, 40% had low physical activity, 16% had low physical function, and 54% had high physical burden. Candidates with impairment in these three physical domains were less likely to be listed (activity: adjusted hazard ratio [aHR] = 0.86, 95% confidence interval [CI]: 0.75–0.99; function: aHR = 0.54, 95%CI: 0.45–0.64; burden: aHR = 0.75, 95%CI: 0.67–0.83) and had a higher risk of waitlist mortality (activity: adjusted sub‐hazard ratio [aSHR] = 1.51, 95%CI: 1.11–2.04; function: aSHR = 1.83, 95%CI: 1.30–2.58; burden: aSHR = 1.40, 95%CI: 1.09–1.82). Physical burden showed the best discrimination in predicting mortality after adjustment (Harrell's C ‐statistic = 0.6899). Conclusion: Although impairment in physical activity, function, and burden was all associated with KT listing and waitlist mortality, physical burden was the strongest predictor of waitlist mortality. KT centers should consider measuring physical burden – a simple, low‐cost tool to help identify high‐risk candidates for prehabilitation.
- 20 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70388
Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality
Background: Frail kidney transplant (KT) candidates, characterized by low physical activity/function, have decreased chances of listing and increased risk of waitlist mortality. Impairments in these physical domains contribute to perceived physical burden and may exacerbate one another. Further, understanding the association of each domain individually with adverse outcomes may improve pre‐KT risk stratification. Methods: We leveraged 2708 KT candidates (age ≥ 18) from a two‐center prospective cohort study (2014–2024). We assessed physical activity (Minnesota Leisure Time Physical Activity Questionnaire), physical function (gait speed), and physical burden (10 questions from the Kidney Disease Quality of Life Short Form) at evaluation. We quantified the association of these three physical domains with listing (Cox proportional hazards) and waitlist mortality (competing risks, Harrell's C ‐statistic). Results: Among 2708 candidates, 40% had low physical activity, 16% had low physical function, and 54% had high physical burden. Candidates with impairment in these three physical domains were less likely to be listed (activity: adjusted hazard ratio [aHR] = 0.86, 95% confidence interval [CI]: 0.75–0.99; function: aHR = 0.54, 95%CI: 0.45–0.64; burden: aHR = 0.75, 95%CI: 0.67–0.83) and had a higher risk of waitlist mortality (activity: adjusted sub‐hazard ratio [aSHR] = 1.51, 95%CI: 1.11–2.04; function: aSHR = 1.83, 95%CI: 1.30–2.58; burden: aSHR = 1.40, 95%CI: 1.09–1.82). Physical burden showed the best discrimination in predicting mortality after adjustment (Harrell's C ‐statistic = 0.6899). Conclusion: Although impairment in physical activity, function, and burden was all associated with KT listing and waitlist mortality, physical burden was the strongest predictor of waitlist mortality. KT centers should consider measuring physical burden – a simple, low‐cost tool to help identify high‐risk candidates for prehabilitation.
- 17 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70376
Ambient Air Pollution, Cognitive Impairment, and Dementia Among Older Patients Being Evaluated for Kidney Transplantation
Background: Older patients who are evaluated for kidney transplantation (KT) experience an earlier onset of cognitive impairment due to dialysis, comorbidities, and inactivity. Ambient fine particulate matter (PM 2.5 ) is a modifiable risk factor for dementia among community‐dwelling older adults. Inflammatory responses and oxidative stress caused by inactivity in older patients evaluated for KT may heighten vulnerability to PM 2.5 . Thus, the impact of PM 2.5 on dementia may be more severe in this population. Methods: We leveraged a prospective cohort (2009–2019) of older (age ≥ 50) patients evaluated for KT ( n = 2073) with Modified Mini‐Mental State Examination (3MS). We derived annual PM 2.5 from residential ZIP codes (high: PM 2.5 > 9 µg/m 3 ), quantifying its association with global cognitive function (linear regression), impairment (logistic regression), and risk of dementia (Cox proportional hazards model). We tested the interaction between PM 2.5 and dementia risk factors using a Wald test. Models were adjusted for confounders, including social determinants of health. Results: High PM 2.5 was associated with worse global cognitive function (difference = −3.00 points [3MS score], 95% CI: −3.93 to −2.07), with a stronger association among patients with low physical activity ( p [interaction] < 0.001). High PM 2.5 was associated with 1.90‐fold higher odds of global cognitive impairment (95% CI: 1.48–2.46), and 3.29‐fold higher risk of dementia (95% CI: 1.14–9.55). Conclusion: High PM 2.5 was associated with worse cognitive function among older patients evaluated for KT, particularly those with low physical activity. The association was stronger than prior findings among community‐dwelling older adults. Clinicians may counsel patients to monitor air quality. Patients in high PM 2.5 neighborhoods should discuss cognitive assessments and ways to increase physical activity with providers.
- 17 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70376
Ambient Air Pollution, Cognitive Impairment, and Dementia Among Older Patients Being Evaluated for Kidney Transplantation
Background: Older patients who are evaluated for kidney transplantation (KT) experience an earlier onset of cognitive impairment due to dialysis, comorbidities, and inactivity. Ambient fine particulate matter (PM 2.5 ) is a modifiable risk factor for dementia among community‐dwelling older adults. Inflammatory responses and oxidative stress caused by inactivity in older patients evaluated for KT may heighten vulnerability to PM 2.5 . Thus, the impact of PM 2.5 on dementia may be more severe in this population. Methods: We leveraged a prospective cohort (2009–2019) of older (age ≥ 50) patients evaluated for KT ( n = 2073) with Modified Mini‐Mental State Examination (3MS). We derived annual PM 2.5 from residential ZIP codes (high: PM 2.5 > 9 µg/m 3 ), quantifying its association with global cognitive function (linear regression), impairment (logistic regression), and risk of dementia (Cox proportional hazards model). We tested the interaction between PM 2.5 and dementia risk factors using a Wald test. Models were adjusted for confounders, including social determinants of health. Results: High PM 2.5 was associated with worse global cognitive function (difference = −3.00 points [3MS score], 95% CI: −3.93 to −2.07), with a stronger association among patients with low physical activity ( p [interaction] < 0.001). High PM 2.5 was associated with 1.90‐fold higher odds of global cognitive impairment (95% CI: 1.48–2.46), and 3.29‐fold higher risk of dementia (95% CI: 1.14–9.55). Conclusion: High PM 2.5 was associated with worse cognitive function among older patients evaluated for KT, particularly those with low physical activity. The association was stronger than prior findings among community‐dwelling older adults. Clinicians may counsel patients to monitor air quality. Patients in high PM 2.5 neighborhoods should discuss cognitive assessments and ways to increase physical activity with providers.
- 22 October 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (10) , e70354
Utilization and Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists in Posttransplant Diabetes Mellitus in Kidney Transplant Recipients
Background: Glucagon‐like peptide‐1 receptor agonists (GLP1RA) provide survival benefits in people with diabetes, including kidney transplant (KT) recipients with pre‐existing diabetes. Post‐transplant diabetes mellitus (PTDM) is common, but the benefits of GLP1RAs remain undefined in this population. We aim to describe current usage practices and outcomes in PTDM. Methods: We used USRDS and Medicare claims data (2013–2022) to conduct a drug utilization profile of GLP1RA among 7681 first‐time adult KT recipients with PTDM. We used survival analysis to estimate GLP1RA initiation incidence and associated patient, graft, and safety outcomes. Results: A total of 430 adult KT recipients with PTDM were prescribed GLP1RA. Dulaglutide was the most commonly prescribed medication (46.1%). The 5‐year cumulative incidence of GLP‐1 receptor agonists prescription was 9.8%. Median (interquartile range) time from PTDM diagnosis to first prescription was 1.7 (0.6, 3.4) years. GLP1RA use was not associated with a difference in the risk of mortality or graft failure but was associated with a 1.80‐fold (95% confidence interval [CI]: 1.11–2.91) increased risk of diabetic retinopathy. No increased risk of pancreatitis, biliary complications, or medullary thyroid cancer were identified. Conclusions: GLP1RA use in KT recipients with PTDM was not associated with graft or patient survival, though longer follow‐up is necessary. GLP1RA use was associated with an increased risk of diabetic retinopathy, and care should be taken when initiating these agents.
- 22 October 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (10) , e70354
Utilization and Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists in Posttransplant Diabetes Mellitus in Kidney Transplant Recipients
Background: Glucagon‐like peptide‐1 receptor agonists (GLP1RA) provide survival benefits in people with diabetes, including kidney transplant (KT) recipients with pre‐existing diabetes. Post‐transplant diabetes mellitus (PTDM) is common, but the benefits of GLP1RAs remain undefined in this population. We aim to describe current usage practices and outcomes in PTDM. Methods: We used USRDS and Medicare claims data (2013–2022) to conduct a drug utilization profile of GLP1RA among 7681 first‐time adult KT recipients with PTDM. We used survival analysis to estimate GLP1RA initiation incidence and associated patient, graft, and safety outcomes. Results: A total of 430 adult KT recipients with PTDM were prescribed GLP1RA. Dulaglutide was the most commonly prescribed medication (46.1%). The 5‐year cumulative incidence of GLP‐1 receptor agonists prescription was 9.8%. Median (interquartile range) time from PTDM diagnosis to first prescription was 1.7 (0.6, 3.4) years. GLP1RA use was not associated with a difference in the risk of mortality or graft failure but was associated with a 1.80‐fold (95% confidence interval [CI]: 1.11–2.91) increased risk of diabetic retinopathy. No increased risk of pancreatitis, biliary complications, or medullary thyroid cancer were identified. Conclusions: GLP1RA use in KT recipients with PTDM was not associated with graft or patient survival, though longer follow‐up is necessary. GLP1RA use was associated with an increased risk of diabetic retinopathy, and care should be taken when initiating these agents.
- Open Access
- 1 October 2025
- Published by Elsevier in AJPM Focus
- Vol. 5 (2) , 100453
Decreasing Prevalence of Chronic Kidney Disease Among U.S. Adults With Diabetes, 1999–2018
- 1 October 2025
- Published by Elsevier in AJPM Focus
- Vol. 5 (2) , 100453
Open AccessDecreasing Prevalence of Chronic Kidney Disease Among U.S. Adults With Diabetes, 1999–2018
- Open Access
- 11 July 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (9) , 1599-1601
The Synergistic Impact of Air Pollution and Residential Neighborhood Segregation on Post–Kidney Transplant Mortality
An abstract is unavailable. This article is available as a PDF only.
- 11 July 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (9) , 1599-1601
Open AccessThe Synergistic Impact of Air Pollution and Residential Neighborhood Segregation on Post–Kidney Transplant Mortality
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 18 June 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (11) , 2387-2397
Sleep disorders and sleep medications as risk factors for dementia in kidney transplant recipients: A retrospective cohort study
- 18 June 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (11) , 2387-2397
Open AccessSleep disorders and sleep medications as risk factors for dementia in kidney transplant recipients: A retrospective cohort study